185 related articles for article (PubMed ID: 9842422)
1. Characterisation of inflammatory cells in benign prostatic hyperplasia.
Anim JT; Udo C; John B
Acta Histochem; 1998 Nov; 100(4):439-49. PubMed ID: 9842422
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic characterization of infiltrating leukocytes in benign prostatic hyperplasia.
Theyer G; Kramer G; Assmann I; Sherwood E; Preinfalk W; Marberger M; Zechner O; Steiner GE
Lab Invest; 1992 Jan; 66(1):96-107. PubMed ID: 1370561
[TBL] [Abstract][Full Text] [Related]
3. Effects of Serenoa repens, selenium and lycopene (Profluss®) on chronic inflammation associated with benign prostatic hyperplasia: results of "FLOG" (Flogosis and Profluss in Prostatic and Genital Disease), a multicentre Italian study.
Morgia G; Cimino S; Favilla V; Russo GI; Squadrito F; Mucciardi G; Masieri L; Minutoli L; Grosso G; Castelli T
Int Braz J Urol; 2013; 39(2):214-21. PubMed ID: 23683667
[TBL] [Abstract][Full Text] [Related]
4. [Early histopathological aspects of benign prostatic hyperplasia: myxoid-inflammatory nodules].
Manzarbeitia F; Vela Navarrete R; Fernández-Aceñero MJ
Actas Urol Esp; 2010 Jun; 34(6):549-54. PubMed ID: 20510119
[TBL] [Abstract][Full Text] [Related]
5. Intraepithelial lymphocytes in relation to NIH category IV prostatitis in autopsy prostate.
Dikov D; Bachurska S; Staikov D; Sarafian V
Prostate; 2015 Jul; 75(10):1074-84. PubMed ID: 25917232
[TBL] [Abstract][Full Text] [Related]
6. Inflammation in benign prostatic hyperplasia: a 282 patients' immunohistochemical analysis.
Robert G; Descazeaud A; Nicolaïew N; Terry S; Sirab N; Vacherot F; Maillé P; Allory Y; de la Taille A
Prostate; 2009 Dec; 69(16):1774-80. PubMed ID: 19670242
[TBL] [Abstract][Full Text] [Related]
7. Correlation between immunohistochemical patterns and serum levels of PSA and PSAP in prostatic pathology: evaluation of 198 prostatic fine needle biopsies.
Vitali A; Ardoino S; Durante P; Ferro MA; Li Causi F; Parodi C; Sanguineti G; Gaffuri M; Paerachino M; Salvadori RP
Anticancer Res; 1994; 14(4A):1503-7. PubMed ID: 7526771
[TBL] [Abstract][Full Text] [Related]
8. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation.
De Nunzio C; Kramer G; Marberger M; Montironi R; Nelson W; Schröder F; Sciarra A; Tubaro A
Eur Urol; 2011 Jul; 60(1):106-17. PubMed ID: 21497433
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of inflammatory cells in benign and precancerous lesions and carcinoma of the prostate.
Fujii T; Shimada K; Asai O; Tanaka N; Fujimoto K; Hirao K; Konishi N
Pathobiology; 2013; 80(3):119-26. PubMed ID: 23328608
[TBL] [Abstract][Full Text] [Related]
10. Distribution of chronic prostatitis in radical prostatectomy specimens with up-regulation of bcl-2 in areas of inflammation.
Gerstenbluth RE; Seftel AD; MacLennan GT; Rao RN; Corty EW; Ferguson K; Resnick MI
J Urol; 2002 May; 167(5):2267-70. PubMed ID: 11956490
[TBL] [Abstract][Full Text] [Related]
11. Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia.
Penna G; Mondaini N; Amuchastegui S; Degli Innocenti S; Carini M; Giubilei G; Fibbi B; Colli E; Maggi M; Adorini L
Eur Urol; 2007 Feb; 51(2):524-33; discussion 533. PubMed ID: 16905241
[TBL] [Abstract][Full Text] [Related]
12. Role of AgNOR count and its correlation with serum PSA levels in prostatic lesions.
Goel T; Garg S
Urol Int; 2009; 82(3):286-90. PubMed ID: 19440015
[TBL] [Abstract][Full Text] [Related]
13. Immunological alterations in the ejaculate of chronic prostatitis patients: clues for autoimmunity.
John H; Maake C; Barghorn A; Zbinden R; Hauri D; Joller-Jemelka HI
Andrologia; 2003 Oct; 35(5):294-9. PubMed ID: 14535858
[TBL] [Abstract][Full Text] [Related]
14. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
15. [Changes in the levels of prostate-specific antigen and its molecular forms with alpha 1-antichymotrypsin in patients with benign prostatic hyperplasia].
Grigor'ev ME; Mazo EB; Chekhonin VP
Urol Nefrol (Mosk); 1998; (4):33-7. PubMed ID: 9727319
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and glandular proliferation in hyperplastic prostates: association with prostate specific antigen value.
Banu NA; Azim FA; Kamal M; Rumi MA; Barua AR; Khan KH
Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):79-83. PubMed ID: 12197626
[TBL] [Abstract][Full Text] [Related]
17. Relationship between serum prostate specific antigen and histological prostatitis in patients with benign prostatic hyperplasia.
Hasui Y; Marutsuka K; Asada Y; Ide H; Nishi S; Osada Y
Prostate; 1994 Aug; 25(2):91-6. PubMed ID: 7518599
[TBL] [Abstract][Full Text] [Related]
18. Autoantibodies to prostate specific antigen in patients with benign prostatic hyperplasia.
Zisman A; Zisman E; Lindner A; Velikanov S; Siegel YI; Mozes E
J Urol; 1995 Sep; 154(3):1052-5. PubMed ID: 7543596
[TBL] [Abstract][Full Text] [Related]
19. An immunohistological study of granulomatous prostatitis.
Dhundee J; Maciver AG
Histopathology; 1991 May; 18(5):435-41. PubMed ID: 1715840
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic characterization of the infiltrating immune cells in normal prostate, benign nodular prostatic hyperplasia and prostatic adenocarcinoma.
Hussein MR; Al-Assiri M; Musalam AO
Exp Mol Pathol; 2009 Apr; 86(2):108-13. PubMed ID: 19111537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]